Kashif M. Munir

Analyses of Public Attention and Sentiments towards Different COVID-19 Vaccines Using Data Mining Techniques

S. Ullah, M. F. Mushtaq, M. S. Fareed, 2022, Vaccines.

A model‐based simulation of glycaemic control and body weight when switching from semaglutide to 3.0‐ and 4.5‐mg doses of once‐weekly dulaglutide

K. Dungan, L. Tham, K. Pantalone, 2021, Diabetes, obesity & metabolism.

Diabetes type 2 management: what are the differences between DPP-4 inhibitors and how do you choose?

Kashif M. Munir, Elizabeth M Lamos, 2017, Expert opinion on pharmacotherapy.

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus

S. Davis, Kashif M. Munir, K. Munir, 2015, Expert opinion on pharmacotherapy.

Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis

Kashif M. Munir, M. Konig, C. Karanikas, 2019, Diabetes Therapy.

Distinct mechanisms for globular adiponectin that integrate vascular and metabolic actions of insulin to help maintain coordinated cardiovascular and glucose homeostasis.

M. Quon, Kashif M. Munir, K. Munir, 2013, Circulation research.